To understand the relationship between TP53 mutations and prognosis in patients with KRAS-mutated lung cancer, we analyzed clinical data from patients with KRAS-mutated lung cancer in The Cancer Genome Atlas using a bioinformatics approach. This evidence concerns the gene KRAS and lung cancer.